Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes re... Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.155 | -30.3921568627 | 0.51 | 0.53 | 0.34 | 59965 | 0.37816181 | CS |
| 4 | -0.065 | -15.4761904762 | 0.42 | 0.68 | 0.34 | 31851 | 0.44360418 | CS |
| 12 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
| 26 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
| 52 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
| 156 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
| 260 | -0.175 | -33.0188679245 | 0.53 | 0.68 | 0.335 | 20221 | 0.43095248 | CS |
gdl
5分前
gdl
7分前
Mr Stock pick
7分前
MDCE_InfiniteAuctions
8分前
desmondfargo
12分前
MDCE_InfiniteAuctions
15分前
Elvispolaris
15分前
InefficientMarket
21分前
jimr1717
22分前
DeerBalls
22分前
MDCE_InfiniteAuctions
25分前
SSKILLZ1
28分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。